RecruitingNot ApplicableNCT07058727

Different Hemostatic Agents Used in Partial Pulpotomy on Pulp Survival and Postoperative Pain

The Effect of Different Hemostatic Agents Used in Partial Pulpotomy on Pulp Survival and Postoperative Pain: A Randomized Clinical Trial


Sponsor

Cukurova University

Enrollment

75 participants

Start Date

May 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized clinical trial evaluates the efficacy of sodium hypochlorite (NaOCl), chlorhexidine (CHX), and cold saline as hemostatic agents in partial pulpotomy. The study compares postoperative pain (via VAS scores) and pulp survival (via clinical/radiographic evaluation) at 1, 3, 7 days, 6 months, and 12 months


Eligibility

Min Age: 15 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Chlorhexidine, a drug called Cold Saline, and others for people with efficacy of hemostatic agents, partial pulpotomy, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 15 Years to 55 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSodium Hypochlorite 2,5%

2.5% NaOCl applied for 1 min to exposed pulp for hemostasis, followed by standard pulp capping

DRUGChlorhexidine

2% CHX applied for 1 min to achieve hemostasis, with identical subsequent steps to NaOCl group

DRUGCold Saline

Hemostasis via 4°C saline (1 Min), then standardized pulp capping


Locations(1)

Çukurova Üniversitesi Diş Hekimliği Fakültesi

Adana, Sarıçam, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07058727


Related Trials